Literature DB >> 19435818

Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.

Xiaoying Zhang1, Ulka Shrikhande, Bethany M Alicie, Qing Zhou, Robert L Geahlen.   

Abstract

The expression of the Syk protein tyrosine kinase in breast cancer cells is inversely correlated with invasive growth and metastasis. The expression of Syk inhibits cell motility while supporting the formation of cell clusters by enhancing cell-cell contacts and promoting the redistribution of the adhesion proteins cortactin and vinculin to these contacts. Syk associates physically with cortactin and catalyzes its phosphorylation on tyrosine. The clustering of integrins leads to the phosphorylation of Syk and of numerous cellular proteins in a manner dependent on the activity of the kinase and on the presence of tyrosine 342 located in the linker B region. The ability of Syk to participate in integrin-mediated protein tyrosine phosphorylation correlates well with its ability to inhibit cell motility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435818      PMCID: PMC2788757          DOI: 10.1158/1541-7786.MCR-08-0371

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  66 in total

1.  Cortactin is required for integrin-mediated cell spreading.

Authors:  András Illés; Balázs Enyedi; Péter Tamás; Annamária Balázs; Gábor Bogel; László Buday
Journal:  Immunol Lett       Date:  2005-12-07       Impact factor: 3.685

2.  Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase.

Authors:  Fei Zhou; Jianjie Hu; Haiyan Ma; Marietta L Harrison; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Structural basis for the requirement of two phosphotyrosine residues in signaling mediated by Syk tyrosine kinase.

Authors:  Teresa D Groesch; Fei Zhou; Sampo Mattila; Robert L Geahlen; Carol Beth Post
Journal:  J Mol Biol       Date:  2005-12-27       Impact factor: 5.469

4.  Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer.

Authors:  Hiroshi Nakashima; Shoji Natsugoe; Sumiya Ishigami; Hiroshi Okumura; Masataka Matsumoto; Shuichi Hokita; Takashi Aikou
Journal:  Cancer Lett       Date:  2005-07-01       Impact factor: 8.679

5.  Expression of Syk in invasive breast cancer: correlation to proliferation and invasiveness.

Authors:  Katerina Repana; Konstantinos Papazisis; Periklis Foukas; Rozalia Valeri; Alexandros Kortsaris; Eleni Deligiorgi; Dimitrios Kyriakidis
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

6.  Epigenetic silencing of novel tumor suppressors in malignant melanoma.

Authors:  Viswanathan Muthusamy; Sekhar Duraisamy; C Matthew Bradbury; Cara Hobbs; David P Curley; Betsy Nelson; Marcus Bosenberg
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

7.  The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for beta2 integrin (CD11/CD18)-mediated neutrophil migration.

Authors:  Jurgen Schymeinsky; Anca Sindrilaru; David Frommhold; Markus Sperandio; Ronald Gerstl; Cornelia Then; Attila Mócsai; Karin Scharffetter-Kochanek; Barbara Walzog
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

8.  The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells.

Authors:  Christoph Hoeller; Christiane Thallinger; Barbara Pratscher; Malena D Bister; Nikolaus Schicher; Robert Loewe; Elisabeth Heere-Ress; Florian Roka; Veronika Sexl; Hubert Pehamberger
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

9.  Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.

Authors:  Lei Wang; Eswaran Devarajan; Jin He; Sekhar P Reddy; Jia Le Dai
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

10.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Authors:  Catherine C Park; Hui Zhang; Maria Pallavicini; Joe W Gray; Frederick Baehner; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

View more
  42 in total

1.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Authors:  Liang Xue; Wen-Horng Wang; Anton Iliuk; Lianghai Hu; Jacob A Galan; Shuai Yu; Michael Hans; Robert L Geahlen; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers.

Authors:  Anton B Iliuk; Victoria A Martin; Bethany M Alicie; Robert L Geahlen; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2010-06-17       Impact factor: 5.911

Review 3.  Cortactin in cell migration and cancer at a glance.

Authors:  Stacey M MacGrath; Anthony J Koleske
Journal:  J Cell Sci       Date:  2012-04-01       Impact factor: 5.285

4.  The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.

Authors:  Kyung D Moon; Xiaoying Zhang; Qing Zhou; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2011-10-12

5.  Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.

Authors:  Brit Neuhaus; Sebastian Bühren; Barbara Böck; Frauke Alves; Wolfgang F Vogel; Friedemann Kiefer
Journal:  Cell Mol Life Sci       Date:  2011-04-17       Impact factor: 9.261

6.  DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Authors:  Catherine L Callahan; Youjin Wang; Catalin Marian; Daniel Y Weng; Kevin H Eng; Meng-Hua Tao; Christine B Ambrosone; Jing Nie; Maurizio Trevisan; Dominic Smiraglia; Stephen B Edge; Peter G Shields; Jo L Freudenheim
Journal:  Epigenetics       Date:  2016-05-31       Impact factor: 4.528

7.  Syk interacts with and phosphorylates nucleolin to stabilize Bcl-x(L) mRNA and promote cell survival.

Authors:  Wen-Horng Wang; Michael O Childress; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

8.  Syk inhibits the activity of protein kinase A by phosphorylating tyrosine 330 of the catalytic subunit.

Authors:  Shuai Yu; He Huang; Anton Iliuk; Wen-Horng Wang; Keerthi B Jayasundera; W Andy Tao; Carol B Post; Robert L Geahlen
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

9.  Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.

Authors:  You Me Sung; Xuehua Xu; Junfeng Sun; Duane Mueller; Kinza Sentissi; Peter Johnson; Elana Urbach; Françoise Seillier-Moiseiwitsch; Michael D Johnson; Susette C Mueller
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

10.  Protein arginine methyltransferase 6 regulates multiple aspects of gene expression.

Authors:  Matthew J Harrison; Yue Hang Tang; Dennis H Dowhan
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.